Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.236NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.153NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.153NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.153NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.302NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.302NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.302NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.194NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.194NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.194NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.55NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.55NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.55NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.51NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.51NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.51NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.308NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.308NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.308NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.138NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.138NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.138NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.379NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.379NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.379NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.240NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.240NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.240NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.240.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.240.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.240.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.121.1 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-1668.53US
AY.121.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.121.1 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-3660.47China
B.1.1.46NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.46NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.46NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.44NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.44NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.44NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GA.10.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KC.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KC.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KC.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KL.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KL.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KL.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HC.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HC.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1212.29Singapore
HC.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used